NUS
NuSkin Enterprises, Inc.
WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
NuSkin Enterprises (NUS) Stock: Buy, Sell, or Hold?
$4.01
+0.12 (+3.08%)
▲
5d:
-11.48%
30d:
-21.53%
90d:
-16.46%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (84%)
Quality Score
49/100
Position
OVERSOLD
30-Day Fair Range
$4.37 – $5.03
Position: OVERSOLD
Forward P/E & Valuation
3.6x
CHEAP
vs 5.1x historical avg
Wall Street Target
$12.48
+211.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.87 / $5.15
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: NUS is down 11.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When NUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$11.22
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$6.97
42.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NUS is currently trading at $4.01, which is considered oversold relative to its 30-day fair value range of $4.37 to $5.03. From a valuation perspective, the stock is trading at a discount (Forward PE: 3.5) compared to its historical average (5.1). Remarkably, the market is currently pricing in an annual earnings decline of 11.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NUS is in a downtrend. Immediate support is located at $3.87, while resistance sits at $5.15. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.48 (+211.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NUS is in a downtrend. Immediate support is located at $3.87, while resistance sits at $5.15. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.48 (+211.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.37 -
$5.03
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
Trading Range & Key Levels
30-Day Trading Range
$4.37 -
$5.03
Current vs Trading Range
OVERSOLD
Support Level
$3.87
Resistance Level
$5.15
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.1%)
- BULLISH: Trading 211.2% below Wall St target ($12.48)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
3.55
Wall Street Target
$12.48
(+211.2%)
Revenue Growth (YoY)
-14.6%
Earnings Growth (YoY)
-98.2%
Profit Margin
-17.7%
Valuation Discount vs History
-11.5% cheaper
PE vs Historical
3.6 vs 5.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-11.5%
(market-implied from PE analysis)
1-Year Target
$3.61
(-10%)
2-Year Target
$3.25
(-19%)
3-Year Target
$2.92
(-27%)
3-Yr Target (if PE normalizes)
(PE: 4→5)
$4.20
(+5%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 88.3%)
$75.74
(+1789%)
Base:
(SPY PE: 3.5, Growth: 88.3%)
$13.53
(+238%)
Bear:
(PE: 3.0, Growth: 88.3%)
$11.50
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 3.5 to 5.1
Stabilization Target:
$5.76
(+43.7%)
PE Expansion Potential:
+43.7%
Share NUS Analysis
Share this live NUS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NUS)
Bullish
4 Retail Mentions
Reddit / WSB Comments
3
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Aug 11, 2026
Daily AI digest
AI Retail Discussion Summary:
One bullish trader on StockTwits disclosed a purchase of $NUS at a price of 4.33.
Key Retail Themes:
Buyer sentiment
Purchase decision
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 8:56 PM ET
Data refreshes hourly during market hours. Next update: 9:56 PM
Data refreshes hourly during market hours. Next update: 9:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Household & Personal Products Stocks
Top-rated stocks in Household & Personal Products by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EL
Estee Lauder Companies I… |
BUY
30 analysts |
$115 | 47 HOLD |
|
PG
Procter & Gamble Company |
BUY
25 analysts |
$174 | 26 SELL |
|
ELF
ELF Beauty Inc |
BUY
18 analysts |
$124 | 42 HOLD |
|
CL
Colgate-Palmolive Company |
BUY
21 analysts |
$102 | 25 SELL |
|
CHD
Church & Dwight Company … |
HOLD
21 analysts |
$110 | 27 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NUS Research Pages
